Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement

American Journal of Cardiology

Volumn 110, Issue 7, 2012, Pages 1021-1026

  Cladellas, Mercè ^a   Farré, Nuria ^a   Comín Colet, Josep ^a   Gómez, Miquel ^a   Meroño, Oona ^a   Bosch, M Alba ^b   Vila, Joan ^b   Molera, Rosa ^b   Segovia, Anna ^b   Bruguera, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC HYDROXIDE SUCROSE; NEO RECORMON; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART VALVE REPLACEMENT; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SUPPLEMENTATION; SURVIVAL; TREATMENT OUTCOME;

EID: 84866113079     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.05.036     Document Type: Article

References (25)

1. H. Kiyama, N. Ohshima, T. Imazeki, T. Yamada Autologous blood donation with recombinant human erythropoietin in anemic patients Ann Thorac Surg 68 1999 1652 1656
2. O. Sowade, H. Warnke, P. Scigalla, B. Sowade, W. Franke, D. Messinger, J. Gross Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery Blood 89 1997 411 418 (Pubitemid 27051675)
3. V.A. Ferraris, J.R. Brown, G.J. Despotis, J.W. Hammon, T.B. Reece, S.P. Saha, H.K. Song, E.R. Clough Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion 2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines Society of Thoracic Surgeons Blood Conservation Guideline Task Force Ann Thorac Surg 91 2011 944 982
4. M. Cladellas, J. Bruguera, J. Comín, J. Vila, E. de Jaime, J. Martí, M. Gomez Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur Heart J 27 2006 1093 1099
5. K. Karkouti, D.N. Wijeysundera, W.S. Beattie Reducing Bleeding in Cardiac Surgery (RBC) Investigators Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study Circulation 117 2008 478 484
6. A.H. van Straten, M.A. Hamad, A.J. van Zundert, E.J. Martens, J.P. Schönberger, A.M. de Wolf Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population Circulation 120 2009 118 125
7. M. Muñoz, D. Ariza, S. Gómez-Ramírez, P. Hernández, J. García-Erce, S. Leal-Noval Preoperative anemia in elective cardiac surgery: prevalence, risk factors, and influence on postoperative outcome Transfus Med 11 2010 47 56
8. D. Zindrou, K.M. Taylor, J.P. Bagger Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery Lancet 359 2002 1747 1748 (Pubitemid 34607091)
9. W.C. Fang, R.E. Helm, K.H. Krieger, T.K. Rosengart, W.J. DuBois, C. Sason, M.L. Lesser, O.W. Isom, J.P. Gold Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery Circulation 96 1997 II-194 II-199
10. G.R. DeFoe, C.S. Ross, E.M. Olmstead, S.D. Surgenor, M.P. Fillinger, R.C. Groom, R.J. Forest, J.W. Pieroni, C.S. Warren, M.E. Bogosian, C.F. Krumholz, C. Clark, R.A. Clough, P.W. Weldner, S.J. Lahey, B.J. Leavitt, C.A. Marrin, D.C. Charlesworth, P. Marshall, G.T. O'Connor Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting Northern New England Cardiovascular Disease Study Group Ann Thorac Surg 71 2001 769 776 (Pubitemid 32210372)
11. R.H. Habib, A. Zacharias, T.A. Schwann, C.J. Riordan, S.J. Durham, A. Shah Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 125 2003 1438 1450 (Pubitemid 36759247)
12. J.B. Williams, B. Phillips-Bute, S.D. Bhattacharya, A.A. Shah, N.D. Andersen, B. Altintas, B. Lima, P.K. Smith, G.C. Hughes, I.J. Welsby Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest J Thorac Cardiovasc Surg 141 2011 1283 1288
13. M.K. Banbury, M.E. Brizzio, J. Rajeswaran, B.W. Lytle, E.H. Blackstone Transfusion increases the risk of postoperative infection after cardiovascular surgery J Am Coll Surg 202 2006 131 138 (Pubitemid 41831483)
14. K. Karkouti, D.N. Wijeysundera, T.M. Yau, S.A. McCluskey, C.T. Chan, P.Y. Wong, W.S. Beattie Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients Anesthesiology 115 2011 523 530
15. I. Gross, A. Shander, J.H. Waters The evidence shows that allogeneic transfusion is associated with reduced survival after coronary artery bypass surgery Anesthesiology 112 2010 760 761
16. Z.S. Bahrainwala, M.A. Grega, C.W. Hogue, W.A. Baumgartner, O.A. Selnes, G.M. McKhann, R.F. Gottesman Intraoperative hemoglobin levels and transfusion independently predict stroke after cardiac operations Ann Thorac Surg 91 2011 1113 1118
17. G. Birgegård, B. Sandhagen Erythropoietin treatment can increase 2,3-diphosphoglycerate levels in red blood cells Scand J Clin Lab Invest 61 2001 337 340 (Pubitemid 32758448)
18. O. Sowade, J. Gross, B. Sowade, H. Warnke, W. Franke, D. Messinger, P. Scigalla, A. Lun, E. Glatzel Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta J Lab Clin Med 129 1997 97 105 (Pubitemid 27506798)
19. G. Haljan, A. Maitland, A. Buchan, R.C. Arora, M. King, J. Haigh, B. Culleton, P. Faris, D. Zygun The Erythropoietin Neuroprotective Effect: Assessment in CABG Surgery (TENPEAKS): a randomized, double-blind, placebo controlled, proof-of-concept clinical trial Stroke 40 2009 2769 2975
20. L. Weltert, S. D'Alessandro, S. Nardella, F. Girola, A. Bellisario, D. Maselli, R. De Paulis Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study J Thorac Cardiovasc Surg 139 2010 621 627
21. Y.C. Yoo, J.K. Shim, J.C. Kim, Y.Y. Jo, J.H. Lee, Y.L. Kwak Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery Anesthesiology 115 2011 929 937
22. J. Comín-Colet, S. Ruiz, M. Cladellas, M. Rizzo, A. Torres, J. Bruguera A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes J Card Fail 15 2009 727 735
23. P. van der Meer, H.F. Groenveld, J.L. Januzzi Jr, D.J. van Veldhuisen Erythropoietin treatment in patients with chronic heart failure: a meta-analysis Heart 95 2009 1309 1314
24. D.S. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, R. Baruch, D. Schwartz, T. Yachnin, S. Steinbruch, I. Shapira, S. Laniado, A. Iaina The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 37 2001 1775 1780 (Pubitemid 32499958)
25. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, T.F. Lüscher, B. Bart, W. Banasiak, J. Niegowska, B.A. Kirwan, C. Mori, B. von Eisenhart Rothe, S.J. Pocock, P.A. Poole-Wilson, P. Ponikowski FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448